Australian Life Scientist
November 3, 2010 by admin
Filed under Media Reports, Media Reports 2010
Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed California-based biopharma company, OncoMed Pharmaceuticals, has announced it will run three Phase Ib clinical trials in Australia and New Zealand testing its humanised monoclonal antibody therapies for cancer. View online article For a licensed copy [CAL] of this article please email us at: [...]
Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals
October 29, 2010 by admin
Filed under Company News, Company News 2010
NOVOTECH INITIATES PHASE IB CANCER TRIALS IN AUSTRALIA AND NEW ZEALAND FOR CLIENT, ONCOMED PHARMACEUTICALS Sydney, Australia, 29 October 2010 – Novotech has announced initiation of three Phase Ib oncology trials at sites in Australia and New Zealand to test the safety, efficacy and pharmacokinetics of client OncoMed’s humanized monoclonal antibody product designed to target [...]
CIO
October 27, 2010 by admin
Filed under Media Reports, Media Reports 2010
Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s Siebel Clinical Trial Management System to support the company’s complete spectrum of clinical drug development and research. Novotech works with leading biotechnology and pharmaceutical companies to bring new healthcare products to [...]
Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth
October 27, 2010 by admin
Filed under Company News, Company News 2010
Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Sydney, Australia – 27 October, 2010 News Facts Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s Siebel Clinical Trial Management System to support the company’s complete spectrum of clinical drug development and research. Novotech works with leading biotechnology and [...]
iTnews
October 26, 2010 by admin
Filed under Media Reports, Media Reports 2010
Novotech runs clinical trials on Oracle A group of three Phase I trials being run by local CRO Novotech is casting a wide net for OncoMed’s cancer-fighting humanised monoclonal antibody OMP-21M18. Novotech has announced that it will license about $500,000 of Oracle Siebel software to help manage clinical research trials at 400 hospitals and health [...]
Outsourcing Pharma
August 25, 2010 by admin
Filed under Media Reports, Media Reports 2010
Podcast: Asia Pacific trial sector poised for continued growth, says Novotech The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian. Outsourcing Pharma Podcast For a licensed copy [CAL] of this article please [...]
Trials In Focus
August 25, 2010 by admin
Filed under Media Reports, Media Reports 2010
Inside Stories – Wide brief for cancer candidate A group of three Phase I trials being run by local CRO Novotech is casting a wide net for OncoMed’s cancer-fighting humanised monoclonal antibody OMP-21M18. The aim of all three trials is to determine the safety, efficacy, pharmacokinetics and maximum tolerated dose of OMR-21M18 when combined with [...]
Trials In Focus
June 21, 2010 by admin
Filed under Media Reports, Media Reports 2010
Inside Stories – Asian trial growth creates hurdles Despite rapid growth in clinical trial activity across Asia, sponsors and CROs need to take care in managing unfamiliar environments says the CEO of Australian-based CRO, Novotech. Alek Safarian told the 46th annual meeting of the Drug Information Association (DIA) in Washington DC last week that regulatory [...]
Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning at the 46th DIA Annual Meeting June 13-17 in Washington, DC
June 15, 2010 by admin
Filed under Company News, Company News 2010
Washington, DC, June 13, 2010 – Leading Australian contract clinical research company Novotech announced today that Novotech CEO Alek Safarian will be sharing the company’s Asia Region expertise and experience at DIA 2010 to be held in Washington, DC. Safarian will speak on “Global Study Experiences: Lessons from Observing Regional Variations” which is part of [...]
CenterWatch
June 4, 2010 by admin
Filed under Media Reports, Media Reports 2010
Novotech Becomes Medidata Solutions’ Partner Medidata Solutions, a global eClinical provider, announced that Australian contract research organization (CRO) Novotech has joined Medidata’s ASPire to Win channel partner program. As Australia’s largest full-service Australian CRO with extensive operations across Asia, Novotech can now offer sponsors a full range of services around the Medidata Rave electronic data [...]








